TrialThe Journal of clinical endocrinology and metabolism2013

The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension.

Henry G Bone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.